Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
2000 1
2002 3
2003 8
2004 19
2005 14
2006 27
2007 31
2008 38
2009 50
2010 61
2011 66
2012 79
2013 64
2014 70
2015 59
2016 46
2017 38
2018 57
2019 59
2020 85
2021 92
2022 79
2023 62
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,006 results

Results by year

Filters applied: . Clear all
Page 1
Phylogenomic analyses provide insights into primate evolution.
Shao Y, Zhou L, Li F, Zhao L, Zhang BL, Shao F, Chen JW, Chen CY, Bi X, Zhuang XL, Zhu HL, Hu J, Sun Z, Li X, Wang D, Rivas-González I, Wang S, Wang YM, Chen W, Li G, Lu HM, Liu Y, Kuderna LFK, Farh KK, Fan PF, Yu L, Li M, Liu ZJ, Tiley GP, Yoder AD, Roos C, Hayakawa T, Marques-Bonet T, Rogers J, Stenson PD, Cooper DN, Schierup MH, Yao YG, Zhang YP, Wang W, Qi XG, Zhang G, Wu DD. Shao Y, et al. Among authors: zhu hl. Science. 2023 Jun 2;380(6648):913-924. doi: 10.1126/science.abn6919. Epub 2023 Jun 1. Science. 2023. PMID: 37262173 Free article.
Reply.
Fang AP, Zhang YJ, Chen MS, Zhu HL. Fang AP, et al. Among authors: zhu hl. Hepatology. 2022 Feb;75(2):491-492. doi: 10.1002/hep.32160. Epub 2021 Dec 18. Hepatology. 2022. PMID: 34536297 No abstract available.
Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.
Mok EHK, Leung CON, Zhou L, Lei MML, Leung HW, Tong M, Wong TL, Lau EYT, Ng IOL, Ding J, Yun JP, Yu J, Zhu HL, Lin CH, Lindholm D, Leung KS, Cybulski JD, Baker DM, Ma S, Lee TKW. Mok EHK, et al. Among authors: zhu hl. Cancer Res. 2022 Sep 2;82(17):3102-3115. doi: 10.1158/0008-5472.CAN-21-2934. Cancer Res. 2022. PMID: 35767704
Nitrogenous Heterocyclic Moiety for Drug Discovery.
Duan Y, Zhu HL. Duan Y, et al. Among authors: zhu hl. Anticancer Agents Med Chem. 2021;21(7):810. doi: 10.2174/187152062107210122115431. Anticancer Agents Med Chem. 2021. PMID: 33829972 No abstract available.
The Research Progress of DPP-4 Inhibitors.
Sun ZG, Li ZN, Zhu HL. Sun ZG, et al. Among authors: zhu hl. Mini Rev Med Chem. 2020;20(17):1709-1718. doi: 10.2174/1389557520666200628032507. Mini Rev Med Chem. 2020. PMID: 32600230 Review.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Yang S, Zhang X, Gale RP, Du X, Chen CY, Weng JY, Huang J, Li F, Zeng Y, Xiao Z, Hu JD, Yang LJ, Liu ZG, Li GH, Sun XL, Yang W, Feng R, Han YQ, Jing Y, Xu N, Liu XL, Liu ZF, Wang XD, Wu SX, Liang R, Zhang YL, Yang YF, Zhu HL, Pan L, Meng L, Zhao YH, Yi H, Liu YL, Zhang WH, Zheng YJ, Zhou ZP, Chen SN, Qiu HY, Li WM, Jia ZL, Bai YL, Lin LE, Liu BC, Liu CS, Luo JM, Meng JX, Sun ZQ, Zhang YQ, Huang XJ, Jiang Q. Yang S, et al. Among authors: zhu hl. Am J Hematol. 2023 Jul;98(7):E183-E186. doi: 10.1002/ajh.26943. Epub 2023 May 2. Am J Hematol. 2023. PMID: 37128776 No abstract available.
1,006 results